首页> 外文OA文献 >Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor
【2h】

Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor

机译:分化因子/白血病抑制因子对小鼠致死性内毒素血症的保护作用:与白介素1和肿瘤坏死因子的协同作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Differentiation factor (D factor), also called leukemia inhibitory factor (LIF), is a glycoprotein that has been increasingly recognized to possess a wide range of physiological activities. We examined the possibility that the administration of D factor may confer beneficial effects and enhance host resistance against lethal endotoxemia. A single intravenous dose of recombinant human D factor completely protected C57/Bl6 mice from the lethal effect of Escherichia coli endotoxin (lipopolysaccharide [LPS]). The protective effects were dose dependent and observed when administered 2-24 h before LPS. Previous work has shown that interleukin 1 (IL-1) and tumor necrosis factor (TNF) also protect against a subsequent LPS challenge in a dose- dependent manner. When human D factor was combined with sub-protective doses of IL-1 beta or TNF-alpha, there was dramatic synergistic protection against a subsequent lethal LPS challenge.
机译:分化因子(D因子),也称为白血病抑制因子(LIF),是一种糖蛋白,已被越来越多地公认具有广泛的生理活性。我们研究了施用D因子可能带来有益作用并增强宿主抵抗致命内毒素血症的可能性。单次静脉注射剂量的重组人D因子可完全保护C57 / Bl6小鼠免受大肠杆菌内毒素(脂多糖[LPS])的致死作用。保护作用是剂量依赖性的,在LPS给药前2-24小时观察到。先前的研究表明,白介素1(IL-1)和肿瘤坏死因子(TNF)也可以剂量依赖的方式防止随后的LPS攻击。当人D因子与亚保护剂量的IL-1β或TNF-α结合使用时,针对随后的致命LPS攻击具有显着的协同保护作用。

著录项

  • 作者

  • 作者单位
  • 年度 1992
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号